Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
743.65
8.45 (1.15%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 86.29 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

86.29 k (-57.02%) Volume

Shareholding (Jun 2026)

FII

8.78%

Held by 17 FIIs

DII

9.05%

Held by 8 DIIs

Promoter

63.85%

Why is Nephrocare Health Services Ltd falling/rising?

06-Sep-2026

As of 05-Sep, Nephrocare Health Services Ltd's stock price is currently Rs 697.35, reflecting a 1.34% decline after a trend reversal. Despite a strong year-to-date performance with a 48.61% increase, the stock has faced a short-term setback due to market conditions and a stagnant month.

As of 05-Sep, Nephrocare Health Services Ltd's stock price is falling, currently at Rs 697.35, which reflects a decrease of Rs 9.5 or 1.34%. This decline follows a trend reversal after three consecutive days of gains. The stock touched an intraday low of Rs 692.65, indicating a drop of 2.01% during the trading day.<BR><BR>Despite this short-term decline, the stock has shown strong performance over the year-to-date, with an increase of 48.61%, significantly outperforming the Sensex, which has decreased by 10.21% in the same period. However, the stock's performance over the past month has been stagnant, with a decline of 2.44%, mirroring the Sensex's performance.<BR><BR>The stock's current fall can be attributed to a combination of factors, including the recent trend reversal and the overall market conditions. Although the company is net-debt free and has reported positive results in the last two quarters, the immediate market reaction has led to a decrease in stock price. Additionally, while there has been a rise in investor participation, as evidenced by a 41.73% increase in delivery volume on September 3, the stock's performance today indicates a temporary setback.

View full answer

Should I buy, sell or hold Nephrocare Health Services Ltd?

04-Sep-2026

What does Nephrocare Healt do?

01-Sep-2026

Nephrocare Health Services Ltd, established in 2009, operates in the healthcare sector, focusing on kidney care services. As of June 2026, it reported net sales of 282 Cr and a net profit of 32 Cr, with a market cap of INR 6,872 Cr.

Overview:<BR>Nephrocare Health Services Ltd operates in the healthcare services industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated in 2009 as "Nephrocare Health Services Private Limited" in Hyderabad. The latest quarterly results reported are for June 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot:<BR>Net Sales: 282 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 32 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 6,872 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 80.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.31 <BR>Return on Equity: 6.88% <BR>Price to Book: 6.24 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

View full answer

Who are the peers of the Nephrocare Healt?

01-Sep-2026

Nephrocare Healt's peers include Indegene, Metropolis Healt, Suven Life Scie., Thyrocare Tech., Vimta Labs, Krsnaa Diagnost., Suraksha Diagno., and Tarsons Products. Thyrocare Tech. and Vimta Labs show excellent management and capital structures, while Suven Life Scie. has the highest 1-year return at 84.49%, and Krsnaa Diagnost. has the lowest at -29.39%.

Peers: The peers of Nephrocare Healt are Indegene, Metropolis Healt, Suven Life Scie., Thyrocare Tech., Vimta Labs, Krsnaa Diagnost., Suraksha Diagno., and Tarsons Products.<BR><BR>Quality Snapshot: Excellent management risk is observed at Thyrocare Tech. and Vimta Labs, while Average management risk is found at Indegene, Metropolis Healt, Krsnaa Diagnost., and the rest. Below Average management risk is present at Suven Life Scie. and Tarsons Products. Growth is rated as Good at Suraksha Diagno., while Below Average growth is seen at Indegene, Metropolis Healt, Suven Life Scie., Krsnaa Diagnost., and the rest. Excellent capital structure is noted at Thyrocare Tech. and Vimta Labs, Good capital structure at Metropolis Healt and Krsnaa Diagnost., and Below Average capital structure at Suven Life Scie. and Tarsons Products.<BR><BR>Return Snapshot: Suven Life Scie. has the highest 1-year return at 84.49%, while Krsnaa Diagnost. has the lowest at -29.39%. Nephrocare Healt's 1-year return is not available for comparison. Additionally, Krsnaa Diagnost. is the only peer with a negative six-month return.

View full answer

How big is Nephrocare Healt?

01-Sep-2026

As of 31st August, Nephrocare Health Services Ltd has a market capitalization of 6,872.00 Cr, with recent net sales of 1,052.82 Cr and a net profit of 85.11 Cr.

As of 31st August, Nephrocare Health Services Ltd has a market capitalization of 6,872.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Nephrocare Health Services Ltd reported Net Sales of 1,052.82 Cr and a Net Profit of 85.11 Cr.<BR><BR>The latest reporting period for the balance sheet is March 2026, with Shareholder's Funds amounting to 1,116.49 Cr and Total Assets of 1,436.90 Cr.

View full answer

Are Nephrocare Health Services Ltd latest results good or bad?

11-Aug-2026

Nephrocare Health Services Ltd's latest results show strong revenue and net profit growth, with a 51.02% increase in net profit to ₹30.37 crores and a 34.65% rise in revenue to ₹265.62 crores. However, the decline in operating margins to 20.25% raises concerns about profitability sustainability, suggesting a mixed outlook for investors.

Nephrocare Health Services Ltd's latest results present a mixed picture. On the positive side, the company reported a net profit of ₹30.37 crores for Q4 FY26, which is a significant increase of 51.02% year-on-year. Additionally, revenue grew by 34.65% year-on-year, reaching ₹265.62 crores, indicating strong demand and successful execution of its expansion strategy.<BR><BR>However, there are concerns regarding profitability metrics. The operating margin decreased to 20.25%, down from 23.43% in the previous quarter, reflecting increased operational costs associated with expansion and inflationary pressures. This margin compression raises questions about the sustainability of profitability moving forward.<BR><BR>Overall, while the revenue and net profit growth are commendable, the decline in operating margins suggests that the company is facing challenges that need to be monitored closely. Investors may view the results as good in terms of growth but should be cautious about the implications of the margin compression.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company is Net-Debt Free

 
2

Low Debt Company with Strong Long Term Fundamental Strength

 
3

With a growth in Net Profit of 15.34%, the company declared Very Positive results in Jun 26

4

With ROE of 6.9, it has a Very Expensive valuation with a 6.7 Price to Book Value

5

Falling Participation by Institutional Investors

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 7,449 Cr (Small Cap)

stock-summary
P/E

88.00

stock-summary
Industry P/E

67

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

6.88%

stock-summary
Price to Book

6.61

Revenue and Profits:
Net Sales:
282 Cr
(Quarterly Results - Jun 2026)
Net Profit:
32 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.88%
0%
2.88%
6 Months
34.37%
0%
34.37%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Nephrocare Health Services Ltd Gains 9.92%: 3 Key Factors Driving the Rally

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

14-Sep-2026 | Source : BSE

Pursuant to Reg 30 of SEBI Listing Regulations we hereby inform you that Nephrocare Health Services Philippines Inc. a step-down wholly owned subsidiary of the Company has acquired a dialysis center and has executed an ATA as per the disclosure annexed herewith.

Disclosure Under Regulation 30 Of The SEBI Listing Regulations - Grant Of Esops Under The Nephroplus Employee Stock Option Scheme 2026.

03-Sep-2026 | Source : BSE

We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith.

Announcement under Regulation 30 (LODR)-Acquisition

01-Sep-2026 | Source : BSE

Pursuant to Reg 30 of SEBI Listing Regulations we wish to hereby inform that NephroPlus Health Services Kazakhstan LLP an overseas subsidiary of the Company has entered into a Share Purchase Agreement for acquisition of 100% participatory interest in Dialysis Center Almaty LLP in Kazakhstan as per the disclosure annexed herewith.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.39
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.84
Tax Ratio
20.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.83%
ROCE (avg)
17.70%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
88
Industry P/E
67
Price to Book Value
6.68
EV to EBIT
52.17
EV to EBITDA
31.33
EV to Capital Employed
9.23
EV to Sales
7.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.70%
ROE (Latest)
6.88%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
No Trend
Bullish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (3.2%)

FIIs

Held by 17 FIIs (8.78%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.7%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 3.68% vs 2.28% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 15.34% vs 28.88% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "170.38",
          "val2": "164.33",
          "chgp": "3.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.15",
          "val2": "22.08",
          "chgp": "9.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.49",
          "val2": "1.27",
          "chgp": "-61.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.56",
          "val2": "10.89",
          "chgp": "15.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.17%",
          "val2": "13.44%",
          "chgp": "0.73%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "629.74",
          "val2": "543.60",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.16",
          "val2": "94.89",
          "chgp": "-7.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "49.76",
          "val2": "14.30",
          "chgp": "247.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-8.06",
          "val2": "34.24",
          "chgp": "-123.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.00%",
          "val2": "17.46%",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
170.38
164.33
3.68%
Operating Profit (PBDIT) excl Other Income
24.15
22.08
9.38%
Interest
0.49
1.27
-61.42%
Exceptional Items
0.00
0.00
Standalone Net Profit
12.56
10.89
15.34%
Operating Profit Margin (Excl OI)
14.17%
13.44%
0.73%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 3.68% vs 2.28% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 15.34% vs 28.88% in Mar 2026

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
629.74
543.60
15.85%
Operating Profit (PBDIT) excl Other Income
88.16
94.89
-7.09%
Interest
49.76
14.30
247.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
-8.06
34.24
-123.54%
Operating Profit Margin (Excl OI)
14.00%
17.46%
-3.46%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Nephrocare Health Services Ltd stock-summary
stock-summary
Nephrocare Health Services Ltd
Small Cap
Healthcare Services
Nephrocare Health Services Limited was incorporated as "Nephrocare Health Services Private Limited", a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009.
Company Coordinates stock-summary
Icon
No Company Details Available